Details for New Drug Application (NDA): 019946
✉ Email this page to a colleague
The generic ingredient in NUROMAX is doxacurium chloride. Additional details are available on the doxacurium chloride profile page.
Summary for 019946
Tradename: | NUROMAX |
Applicant: | Abbvie |
Ingredient: | doxacurium chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/ML | ||||
Approval Date: | Mar 7, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 019946
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | NUROMAX | doxacurium chloride | INJECTABLE;INJECTION | 019946-001 | Mar 7, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription